文献速递心力衰竭与心肌病冠心病

血浆蛋白质组学与单细胞转录组学优先筛选心肌梗死后心力衰竭候选标志物

Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics.
PubMed 文献 · Circulation · 2020-09-04

研究利用aptamer血浆蛋白质组学在新西兰CDCS队列(181例心衰住院患者 vs 250例无事件患者)中检测心梗后1个月的1305种血浆蛋白,结合新加坡IMMACULATE队列(223例,33例心衰住院)进行跨队列验证,并交叉参照小鼠及人类单细胞转录组数据,最终从三个数据集共有的蛋白中优先筛选出6种高度富集蛋白,包括NT-proBNP、肌钙蛋白T及血管生成素-2、血小板反应蛋白-2、潜在转化生长因子-β结合蛋白-4、卵泡抑素相关蛋白-3等新标志物。

要点

  • 血浆蛋白质组学联合单细胞转录组可优先筛选心梗后心衰候选蛋白。
  • 三个数据集共有的6种高度富集蛋白中包括NT-proBNP和肌钙蛋白T等已知标志物。
  • 血管生成素-2、血小板反应蛋白-2等为新发现的心梗后心衰候选标志物。

核心结论

  • 大规模人类血浆蛋白质组学与单细胞分辨率的心脏转录组学交叉参照,可优先筛选出与心梗后心衰相关的蛋白候选物,供进一步机制和临床验证。

研究设计与样本

  • 新西兰CDCS队列:181例心梗后因心衰住院患者与250例随访中无事件患者,心梗后1个月检测1305种血浆蛋白,中位随访4.9年。
  • 新加坡IMMACULATE队列:223例心梗后患者,其中33例因心衰住院,中位随访2.0年,用于候选蛋白富集验证。
  • 交叉参照小鼠心梗模型非心肌细胞单细胞转录组、小鼠心衰模型及人类心衰患者心肌细胞单细胞/单核转录组。

主要发现

  • CDCS队列中212种差异表达血浆蛋白与后续心衰事件显著相关,其中96种与心梗后4个月测定的左心室射血分数相关。
  • 加权基因共表达网络分析从212种蛋白中优先筛选出63种,这些蛋白在心梗后心衰患者中的相关性显著高于无事件对照。
  • IMMACULATE队列跨队列荟萃分析识别出36种与心梗后心衰相关的血浆蛋白。
  • 单细胞转录组识别出15种基因-蛋白候选物。
  • 三个数据集共有的6种高度富集蛋白包括NT-proBNP、肌钙蛋白T、血管生成素-2、血小板反应蛋白-2、潜在转化生长因子-β结合蛋白-4和卵泡抑素相关蛋白-3。

临床怎么用

  • NT-proBNP和肌钙蛋白T仍是心梗后心衰的成熟生物标志物,新候选蛋白如血管生成素-2等需进一步机制和临床验证。
  • 血浆蛋白质组学联合单细胞转录组学可作为发现心梗后心衰生物标志物和药物靶点的筛选策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heart failure (HF) is the most common long-term complication of acute myocardial infarction (MI). Understanding plasma proteins associated with post-MI HF and their gene expression may identify new candidates for biomarker and drug target discovery. METHODS: We used aptamer-based affinity-capture plasma proteomics to measure 1305 plasma proteins at 1 month post-MI in a New Zealand cohort (CDCS [Coronary Disease Cohort Study]) including 181 patients post-MI who were subsequently hospitalized for HF in comparison with 250 patients post-MI who remained event free over a median follow-up of 4.9 years. We then correlated plasma proteins with left ventricular ejection fraction measured at 4 months post-MI and identified proteins potentially coregulated in post-MI HF using weighted gene co-expression network analysis. A Singapore cohort (IMMACULATE [Improving Outcomes in Myocardial Infarction through Reversal of Cardiac Remodelling]) of 223 patients post-MI, of which 33 patients were hospitalized for HF (median follow-up, 2.0 years), was used for further candidate enrichment of plasma proteins by using Fisher meta-analysis, resampling-based statistical testing, and machine learning. We then cross-referenced differentially expressed proteins with their differentially expressed genes from single-cell transcriptomes of nonmyocyte cardiac cells isolated from a murine MI model, and single-cell and single-nucleus transcriptomes of cardiac myocytes from murine HF models and human patients with HF. RESULTS: In the CDCS cohort, 212 differentially expressed plasma proteins were significantly associated with subsequent HF events. Of these, 96 correlated with left ventricular ejection fraction measured at 4 months post-MI. Weighted gene co-expression network analysis prioritized 63 of the 212 proteins that demonstrated significantly higher correlations among patients who developed post-MI HF in comparison with event-free controls (data set 1). Cross-cohort meta-analysis of the IMMACULATE cohort identified 36 plasma proteins associated with post-MI HF (data set 2), whereas single-cell transcriptomes identified 15 gene-protein candidates (data set 3). The majority of prioritized proteins were of matricellular origin. The 6 most highly enriched proteins that were common to all 3 data sets included well-established biomarkers of post-MI HF: N-terminal B-type natriuretic peptide and troponin T, and newly emergent biomarkers, angiopoietin-2, thrombospondin-2, latent transforming growth factor-β binding protein-4, and follistatin-related protein-3, as well. CONCLUSIONS: Large-scale human plasma proteomics, cross-referenced to unbiased cardiac transcriptomics at single-cell resolution, prioritized protein candidates associated with post-MI HF for further mechanistic and clinical validation.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Chan MY, Efthymios M, Tan SH, et al. Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics. Circulation. 2020. PMID: 32885678. doi:10.1161/CIRCULATIONAHA.119.045158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。